| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3.86k | 0.00 | Derivative Exercise and Retained Stock | - | 46.82k | 8.99% |
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -2.16k | 2.66k | Derivative Exercise and Sale | 1.23 | 46.82k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | -2.69k | 3.31k | Derivative Exercise and Sale | 1.23 | 42.04k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | 6.76k | 0.00 | Derivative Exercise and Retained Stock | - | 42.04k | 19.15% |
| 2026-05-20 | Mr. Peter D. KiesCFO | 4.01k | 0.00 | Derivative Exercise and Retained Stock | - | 43.23k | 10.23% |
| 2026-05-20 | Mr. Peter D. KiesCFO | -4.69k | 5.77k | Derivative Exercise and Sale | 1.23 | 43.23k | - |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | 15.99k | 0.00 | Derivative Exercise and Retained Stock | - | 111.02k | 16.83% |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | -12.31k | 15.14k | Derivative Exercise and Sale | 1.23 | 111.02k | - |
| 2026-05-15 | Mr. Peter D. KiesCFO | 2.20k | 0.00 | Derivative Exercise and Retained Stock | - | 39.22k | 5.94% |
| 2026-05-15 | Mr. Peter D. KiesCFO | -2.57k | 3.34k | Derivative Exercise and Sale | 1.30 | 39.22k | - |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | 10.03k | 0.00 | Derivative Exercise and Retained Stock | - | 95.03k | 11.80% |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | -7.72k | 10.03k | Derivative Exercise and Sale | 1.30 | 95.03k | - |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3.06k | 0.00 | Derivative Exercise and Retained Stock | - | 42.96k | 7.67% |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -1.71k | 2.23k | Derivative Exercise and Sale | 1.30 | 42.96k | - |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | 1.71k | 0.00 | Derivative Exercise and Retained Stock | - | 35.28k | 5.08% |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | -680.00 | 884.00 | Derivative Exercise and Sale | 1.30 | 35.28k | - |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 33.58k | 10.06% |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | -1.22k | 2.13k | Derivative Exercise and Sale | 1.74 | 33.58k | - |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 7.28k | 0.00 | Derivative Exercise and Retained Stock | - | 39.90k | 22.31% |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -5.10k | 9.13k | Derivative Exercise and Sale | 1.79 | 39.90k | - |
| 2026-02-26 | Mr. Peter D. KiesCFO | 6.39k | 0.00 | Derivative Exercise and Retained Stock | - | 37.02k | 20.84% |
| 2026-02-26 | Mr. Peter D. KiesCFO | -9.26k | 16.57k | Derivative Exercise and Sale | 1.79 | 37.02k | - |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | 25.32k | 0.00 | Derivative Exercise and Retained Stock | - | 85.00k | 42.42% |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | -21.71k | 38.87k | Derivative Exercise and Sale | 1.79 | 85.00k | - |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | 12.66k | 0.00 | Derivative Exercise and Retained Stock | - | 30.51k | 70.91% |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | -3.90k | 6.99k | Derivative Exercise and Sale | 1.79 | 30.51k | - |
| 2026-02-26 | Dr. David B. WeinerMember of the Scientific Advisory Board & Director | 972.00 | 0.00 | Derivative Exercise and Retained Stock | - | 87.59k | 1.12% |
| 2025-06-30 | Dr. Michael SumnerChief Medical Officer & Head of Development | 2.92k | 0.00 | Derivative Exercise and Retained Stock | - | 17.85k | 19.53% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。